ADITX Therapeutics
$0.00 (0.00%) As of 12:05 PM UTC pre-market
Why Robinhood?
You can buy or sell ADTX and other stocks, options, and ETFs commission-free!
About ADTX
ADiTx Therapeutics, Inc. engages in the development of biotechnologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. It has a worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue.
CEO
Amro Albanna
Employees
43
Headquarters
Mountain View, California
Founded
2017
ADTX Key Statistics
Market Cap
42.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
150.57K
High Today
$2.94
Low Today
$2.84
Open Price
$2.94
Volume
44.54K
52 Week High
$9.58
52 Week Low
$1.62
ADTX Earnings
-$0.46
-$0.31
-$0.15
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours